STOCK TITAN
  1. Home
  2. News
  3. RVMD

Revolution Medicines Inc - RVMD STOCK NEWS

IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
offering
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock
offering
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Proposed Public Offering of Common Stock
offering
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Reports New Application of Tri-Complex Modality for “Undruggable” Protein Targets and Announces License to Ginkgo Bioworks to Explore Potential Use Against Novel Coronavirus
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Provides Research and Development Update for its Portfolio of Novel Targeted Cancer Therapies
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor
clinical trial
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Appoints Eric T. Schmidt, Ph.D. and Peter Svennilson to its Board of Directors
management
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510
clinical trial
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models
Stock RVMD logo
Revolution Medicines Inc

Nasdaq:RVMD

RVMD Rankings

#1663 Ranked by Market Cap
#2552 Ranked by Stock Gains
N/A Ranked by Dividends

RVMD Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Redwood City

About RVMD

revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.